Rock Creek Pharmaceuticals, Inc. announced earnings results for the first quarter ended March 31, 2015. The company recorded a net loss of approximately $0.3 million for the three months ended March 31, 2015, compared to a net loss of approximately $9.8 million for the same period in 2014. The decreased net loss for the three months ended March 31, 2015 was primarily due to cost savings in relation to the restructuring, a decrease in non-cash expenditures related to stock based compensation, and non-recurring other income from insurance proceeds.

The company had a total basic and diluted loss per share of $0.04, compared to a total net loss per share of $1.41 at March 31, 2014.